DarioHealth

Company Overview

Snapshot

Founded in September 2011 by Dov Oppenheim, DarioHealth operates with 201–500 employees. The company has raised over $268.11 million across 18 funding rounds and is publicly traded on NASDAQ. In February 2024, DarioHealth acquired Twill, a digital health company, significantly expanding its platform across chronic conditions.

Business overview

DarioHealth is a global digital therapeutics company focused on revolutionizing chronic condition management. The company's core offering includes AI-powered digital therapeutic solutions that provide adaptive, personalized experiences to drive behavior change through evidence-based interventions, high-quality software, coaching, and clinically proven digital tools. DarioHealth serves markets at the intersection of life sciences, behavioral science, and software technology, with a focus on diabetes, hypertension, and expanding into new chronic conditions and geographic markets.

Strategic signal

In September 2025, DarioHealth announced a strategic review following multiple unsolicited inbound expressions of interest. This indicates significant market validation and potential for major corporate developments, suggesting a pivotal moment for the company's future trajectory and strategic positioning within the digital health market.

Company Intelligence Q&A

What was a significant recent financial event for DarioHealth?

In July 2026, DarioHealth announced the pricing of a $23.5 million registered direct offering of common stock, priced at-the-market under Nasdaq rules.

What strategic collaboration did DarioHealth announce in October 2025?

In October 2025, DarioHealth and OneStep announced a strategic collaboration to integrate OneStep's smartphone-only, clinical-grade fall risk assessment technology into Dario's digital health multi-condition platform.

What acquisition did DarioHealth complete in February 2024?

In February 2024, DarioHealth acquired Twill, creating a more comprehensive digital health platform across various chronic conditions.

What research did Dario publish in September 2023?

In September 2023, Dario published new research demonstrating clinically significant reductions in depression through its digital behavioral health programs.

What partnership did DarioHealth announce in September 2020?

In September 2020, DarioHealth and HMC HealthWorks announced a partnership agreement.